Navigation Links
Symphogen Grants Exclusive Worldwide License of Phase II Oncology Drug Candidate Sym004 to Merck KGaA
Date:9/5/2012

accessed via http://www.symphogen.com

Seven day replay dial-in details:

Tel: +44(0)1452-550-000

Conference ID: 28172177

About Symphogen

Symphogen is developing antibody therapeutics (monoclonal, monoclonal mixtures and polyclonal) to help people with serious diseases and significant unmet medical needs. With its proprietary Symplex™ discovery, SymSelect™ lead selection and Sympress™ manufacturing platforms, the company captures the diversity and specificity of the natural immune response in rationally designed recombinant antibody mixtures. Symphogen is maturing a diversified pipeline of internal and partnered products across multiple indications including cancer, autoimmune and infectious disease. Symphogen is a private biopharmaceutical company headquartered in Copenhagen, Denmark, with a US subsidiary in Princeton, New Jersey. For more information, please visit http://www.symphogen.com.

About Merck Serono

Merck Serono is the biopharmaceutical division of Merck KGaA. With headquarters in Darmstadt, Germany, Merck Serono offers leading brands in 150 countries to help patients with cancer, multiple sclerosis, infertility, endocrine and metabolic disorders as well as cardiovascular diseases. In the United States and Canada, EMD Serono operates as a separately incorporated subsidiary of Merck Serono.

Merck Serono discovers, develops, manufactures and markets prescription medicines of both chemical and biological origin in specialist indications. We have an enduring commitment to deliver novel therapies in our core focus areas of neurodegenerative diseases, oncology and rheumatology.

About Merck

Merck is a global pharmaceutical and chemical company with total revenues of €10.3 billion in 2011, a history that began in 1668, and a future shaped by more than 40,000 employees in 67 countries. Its succe
'/>"/>

SOURCE Symphogen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. The Leukemia & Lymphoma Society Awards $12 Million in Research Grants in Four Critical Areas of Unmet Medical Need
2. USPTO Grants Butamax a Further KARI Enzyme Patent
3. Enox Biopharma, Inc. Grants TTA LTD License To Wound Care Applications
4. FDA Grants Lexicon Orphan Drug Designation for Telotristat Etiprate for the Treatment of Carcinoid Syndrome
5. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
6. NSF CAREER grants support ocean energy, microforming, computer planning
7. Maryland Stem Cell Research Commission Announces New Program for Pre-Clinical and Clinical Research Grants
8. Elsevier Foundation Awards 2011 Grants to Advance Women in Science and Support Libraries in Developing Countries
9. Free Job Training: 55 Grants Available to Retrain Workers for Biofuels Industry
10. Pinnaclife, Inc., Announces NDC, Inc., to Exclusively Distribute the New Animal Health Product Line!
11. MO BIO Laboratories, Inc. Becomes Exclusive Sponsor Of Natures Human Microbiota Special
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015 Veracyte, Inc. (NASDAQ: VCYT ... president and chief executive officer, will present at the ... 2015 at 10:30 a.m. ET in New ... audio webcast and subsequent replay may be accessed by ... available shortly after conclusion of the presentation and archived ...
(Date:9/2/2015)... ... 2015 , ... Advancing in medical imaging processing technology has ... in ICU to 3D skull printing analysis for Neurosurgery, ONYX ZEUS all-in-one surgical ... simultaneous access to high precision medical images and electronic health records. , ...
(Date:9/2/2015)... ... September 02, 2015 , ... Genedata, ... research, today unveiled Genedata Screener ® version 13.0 at ELRIG Drug Discovery ... to market a rich set of new capabilities. Screener now supports High Throughput ...
(Date:9/1/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), ... of targeted antiviral therapies, announced today that it will ... Annual Global Investment Conference sponsored by H.C. Wainwright ... The St. Regis Hotel in New York, ... , Chief Executive Officer, will provide an overview of ...
Breaking Biology Technology:Veracyte to Present at Morgan Stanley Global Healthcare Conference 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2
... Eniva Research Group has,released results from aboratory ... Institute at Oregon State University which,demonstrated the ... activity for human cells. This third party ... investigative effort to further identify,mechanisms by which ...
... Technologies Inc. and Isis,Pharmaceuticals, Inc. (NASDAQ: ISIS ... agreement and OncoGenex has elected to independently,develop its ... is solely responsible for all future development activities,costs ... no longer be,responsible for funding 35% of development ...
... Inc. (Amex:,ADL), a world leader in specialty pharmaceuticals ... and Jilin, China, announced,today it has released its ... Company,s website at http://www.amdl.com ., About ... pharmaceutical company. The company is,headquartered in Tustin, California ...
Cached Biology Technology:Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2OncoGenex increases economic interest in lead cancer drug OGX-011 2OncoGenex increases economic interest in lead cancer drug OGX-011 3OncoGenex increases economic interest in lead cancer drug OGX-011 4AMDL Announces Investor Relations Presentation Available on Website 2
(Date:8/12/2015)... 2015   MedNet Solutions , an innovative SaaS-based ... clinical research, is proud to announce that ... eClinical technology platform, has led the way to significant ... of 2015.   Q2 2015 and Q1 2015 were, ... contract value sold in the company,s 15 year history.  ...
(Date:8/12/2015)... , Aug. 12, 2015  Synaptics Inc. ... human interface solutions, today announced that four of ... Match-in-Sensor solution, have officially been named FIDO Certified™ ... part of the certification, Synaptics, Natural ID™ fingerprint ... Universal Authentication Framework (UAF) standard and are interoperable ...
(Date:8/10/2015)... , August 10, 2015 The ... offers comprehensive analysis of the global border security ... generate revenues of $16.4bn in 2015. Now: Border ... is an example of the business critical issue you need ... read visiongain ,s objective analysis of how this will ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 2Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 4Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 5Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 7Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 8Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 9
... belief that specific dietary changes can improve the symptoms of ... University of Rochester study, which found that eliminating gluten and ... impact on their behavior, sleep or bowel patterns. ... to date. The researchers took on the difficult yet crucial ...
... May 18, NASA,s Aqua satellite swept over the Gulf of ... the Moderate Resolution Imaging Spectroradiometer instrument captured sunglints in a ... three bright areas of sunglint within the area of the ... sun off the water,s surface. In calm waters, the rounded ...
... you know what is in your drinking water? A study ... thinking twice the next time you fill up that glass ... sciences professor in the College of Arts and Sciences, sampled ... concentrations of viruses and bacteria linked to human feces that ...
Cached Biology News:Popular autism diet does not demonstrate behavioral improvement 2Popular autism diet does not demonstrate behavioral improvement 3UT study finds viruses in untreated East Tennessee drinking water 2
Mouse monoclonal antibody raised against a partial recombinant TPR. NCBI Entrez Gene ID = TPR...
... be used to test the crossreactivity of ... that are commonly used as blocking reagents ... for 19 different protein preparations on a ... and species specificity, QC of purified antibodies, ...
... Each kit contains sufficient materials for 1,464 array sample ... Membrane: 4 each , Blocker BSA in PBS ... mg , BupH Phosphate Buffered Saline: 8 packs ... , SuperSignal West Pico Luminol Enhancer: 2 x 25 ...
... Each kit contains sufficient materials for 1,464 array sample ... 4 each , Blocker BSA in ... Anti-Mouse Antibody, HRP-conjugated: 10 g , ... , 10% Tween-20: 2 x 10 ml ampules ...
Biology Products: